Benzinga LA Interviews: Ian Rassman: Executive Director, President NORML
About the Author: HCN News Team
The News Team at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.
Related Posts
Latest News
Psilocybin Study Suggests Potential for Longevity Benefits
LOS ANGELES- New preclinical research indicates that psilocybin the active psychoactive compound in psychedelic mushrooms—may significantly extend lifespan in both human cells and aged mice. Published July 8, 2025, in npj Aging, the study found ...
Challenges Emerge Over Kentucky’s Medical Cannabis License Lottery
LOS ANGELES- A coalition of Kentucky-based businesses has filed legal proceedings challenging the fairness and constitutionality of the state’s April 2024 medical cannabis license lottery. The lawsuit, lodged in Jefferson Circuit Court on June 27, ...
Aegis Capital Maintains Buy Rating on atai Life Sciences with $8 Target
LOS ANGELES- Aegis Capital has reaffirmed its Buy rating on atai Life Sciences N.V. (NASDAQ: ATAI), maintaining a price target of $8 following the release of positive Phase 2b results for BPL-003, the company’s investigational ...
